Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study ; volume:195 ; number:2 ; day:31 ; month:7 ; year:2022 ; pages:209-221 ; date:9.2022
Breast cancer research and treatment ; 195, Heft 2 (31.7.2022), 209-221, 9.2022
- Urheber
-
McVicker, Lauren
Cardwell, Christopher R.
McIntosh, Stuart A.
McMenamin, Úna C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-022-06674-5
- URN
-
urn:nbn:de:101:1-2022112709325980562244
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McVicker, Lauren
- Cardwell, Christopher R.
- McIntosh, Stuart A.
- McMenamin, Úna C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
Effects of marital status on overall and cancer-specific survival in laryngeal cancer patients: a population-based study
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer
Identification of unique rectal cancer-specific subtypes
Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality
Inherent variability of cancer-specific aneuploidy generates metastases
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations
ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer
Common germline polymorphisms associated with breast cancer-specific survival
Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
Effects of marital status on overall and cancer-specific survival in laryngeal cancer patients: a population-based study
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer
Identification of unique rectal cancer-specific subtypes
Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality
Inherent variability of cancer-specific aneuploidy generates metastases
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations
ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer
Common germline polymorphisms associated with breast cancer-specific survival
Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
Effects of marital status on overall and cancer-specific survival in laryngeal cancer patients: a population-based study
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer
Identification of unique rectal cancer-specific subtypes
Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality
Inherent variability of cancer-specific aneuploidy generates metastases
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations
ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer